Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O-desmethyl metabolites of erlotinib and gefitinib in human plasma.

Show more authors
+ 2
Rolf W Sparidans
Hilde Rosing
Johannes J M Rood
Jan H M Schellens
Jos H Beijnen

More about this publication

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Volume 1033-1034
Pages 390-398
Publication date 15-10-2016

Full text links

Publisher website (DOI) 10.1016/j.jchromb.2016.09.012
Europe PubMed Central 27639128
Pubmed 27639128

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.